Monday, July 4, 2016

BRIEF-Regeneron and Sanofi announce approval of praluent (alirocumab) in Japan

* Regeneron and Sanofi announce approval of

praluent (alirocumab) for the treatment of hypercholesterolemia

in Japan

Source text for Eikon:

Further company coverage:

(Gdynia Newsroom)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)